PI Digital combines a collaborative engagement model with a strong commercial focus to develop customized digital solutions, including for regulated medical environments.
Medtech industry veteran Euan Pizzey and accomplished executive Lisa Hennessy have been appointed to the PI Board to help achieve our vision of becoming Australia’s leading incubator of high-growth technology companies.
PI has entered into an agreement with Imagion Biosystems, a company dedicated to improving healthcare through the earlier detection of cancer, to develop Imagion’s MagSense instrument technology.
Speaking at an American Chamber of Commerce event, our Co-CEO and Co-founder Stuart Elliott offered insight into three fundamentals that organizations need to get right if they are serious about innovation.
Atmo Biosciences, a Planet Innovation early stage venture, has signed a licensing deal with RMIT University to secure the exclusive worldwide rights to a ground-breaking ingestible gas-sensing capsule.
Lumos Diagnostics is expanding its global footprint after agreeing an ongoing manufacturing deal for a customized lateral flow reader with a California-based life sciences company.
An RMIT University researcher working with PI on technology that can test patients for bleeding or clotting disorders has been awarded more than $650,000 in NHMRC funding.
Planet Innovation has been selected as one of Australia’s Top 20 Businesses of Tomorrow from more than 1,000 applications.